hydroxyindoleacetic acid has been researched along with Prostatic Hyperplasia in 1 studies
(5-hydroxyindol-3-yl)acetic acid : A member of the class of indole-3-acetic acids that is indole-3-acetic acid substituted by a hydroxy group at C-5.
Prostatic Hyperplasia: Increase in constituent cells in the PROSTATE, leading to enlargement of the organ (hypertrophy) and adverse impact on the lower urinary tract function. This can be caused by increased rate of cell proliferation, reduced rate of cell death, or both.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (100.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Cockett, AT | 1 |
| di Sant'Agnese, PA | 1 |
| Gopinath, P | 1 |
| Schoen, SR | 1 |
| Abrahamsson, PA | 1 |
1 other study available for hydroxyindoleacetic acid and Prostatic Hyperplasia
| Article | Year |
|---|---|
Relationship of neuroendocrine cells of prostate and serotonin to benign prostatic hyperplasia.
Topics: Aged; Chromatography, High Pressure Liquid; Humans; Hydroxyindoleacetic Acid; Immunohistochemistry; | 1993 |